MCAired: Can the emerging UK medical cannabis market compete with the entrenched black market?

MCAired: Can the emerging UK medical cannabis market compete with the entrenched black market?

In our first podcast Neil Cartwright from Releaf (Australia) asserted that the target market for his business in Australia was unequivocally converting black market cannabis users to the legal medical cannabis market. Is this also the foundation basis of the UK market? Or does attracting so-called ‘cannabis naive’ patients provide a more viable demographic to build a sustainable medical cannabis business? Is the real competition in the UK not between clinics but instead between all clinics and the illicit market? Steve Moore, MCA Founder, discusses with Nick Pateras, former CEO of Lyphe Group & Materia Ventures and Graham Woodward, COO of Releaf UK (note: different company to Releaf Australia). From regulatory hurdles to consumer perceptions, we explore the factors shaping the future of medical cannabis in the UK. Tune in for insightful analysis, candid discussions, and actionable insights on this topic.

MCAired: What can the UK Medical Cannabis Market Learn from Australia?

Join us as we go right into the heart of the medical cannabis industry in the UK with MCAired.  Our new podcast, hosted by MCA Founder Steve Moore, will confront hard truths and not indulge comfortable delusions. We recognise the potential for the industry but also the challenges we face as companies and an industry.  The first in the series focuses on Australia and asks what lessons the UK medical cannabis industry can learn from their successes and mistakes. Panel of experts Karen Bowell - Managing Director, Althea Global Clare Barker - Medical Cannabis Consultant Neil Cartwright - Head of Product, Releaf Professor Iain S McGregor - Professor of Psychopharmacology, Academic Director, Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney